Janney Montgomery Scott’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-39,579
Closed -$924K 2665
2023
Q2
$924K Buy
39,579
+219
+0.6% +$5.25K ﹤0.01% 1466
2023
Q1
$916K Sell
39,360
-1,381
-3% -$34.5K ﹤0.01% 1367
2022
Q4
$1.02M Buy
+40,741
New +$1.09M ﹤0.01% 1363

Other funds holding IDNA

Janney Montgomery Scott's IDNA Position: Q3 2023 in Review

Janney Montgomery Scott sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2023, closing a stake of 39,579 shares — an estimated $924K sold.

Janney Montgomery Scott first reported a position in IDNA in Q4 2022 and held it in 3 quarters. The position peaked at $1.02M in Q4 2022. 66 funds tracked by Wall St. Rank hold IDNA as of Q3 2023.

  • Janney Montgomery Scott reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 39,579 iShares Genomics Immunology and Healthcare ETF shares in Q3 2023, an estimated $924K.
  • Janney Montgomery Scott first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2022 and held it in 3 quarters.
  • Janney Montgomery Scott's iShares Genomics Immunology and Healthcare ETF position peaked at $1.02M in Q4 2022.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2023.

Based on Janney Montgomery Scott's 13F filing for Q3 2023, filed 8 Nov 2023.